It seems biofabricated tissues mean business. But the translation of biofabricated tissues into broader use beyond laboratory settings is a considerable challenge, in some cases industries such as animal testing for screening and treatment flows in clinical settings may have to change to accommodate them. The organisation committee would like to invite you to join us in a highly interactive exploratory gathering, to address: What are the key elements that have to be in place for biofabricated tissues for clinical use and organ-on-a-chip devices?.